National trends in buprenorphine prescribing before and during the COVID-19 pandemic.  Ali MM, Creedon TB, Jacobus-Kantor L, Sherry TB.  J Subst Abuse Treat. 2023 Jan;144:108923. doi: 10.1016/j.jsat.2022.108923. Epub 2022 Oct 29. PMID: 3…

Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs.  Krawczyk N, Maniates H, Hulsey E, Smith JS, DiDomenico E, Stuart EA, Saloner B, Bandara S.  J Addict Med. 20…

Triple Threat: Response to the Crises of COVID-19, Homelessness, and Opioid Use Disorder With a Novel Approach to Buprenorphine Delivery: A Case Series.  Samuel L, Caygill-Walsh R, Suen LW, Mohebbi S, Geier M.  J Addict Med. 2022 Nov-Dec…

Impacts of the New York State COVID-19 Disaster Emergency Orders on prescription dispensing for opioids and medication for opioid use disorder.  Suri A, Feaster DJ, Balise RR, Quinn J, Nunes EV, Gilbert L, El-Bassel N, Rundle AG. Addiction. 2…

HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic during a Local HIV Outbreak at the Onset of the COVID-19 Pandemic.  Braun HM, Walter C, Farrell N, Biello KB, Taylor JL.  J Addict Med. 2022 Nov-Dec…

Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel.  Wiessing L, Sypsa V, Abagiu AO, Arble A, B…